No description

EurOPDX Research Infrastructure Trans-national access (TA) program

Trans-national access (TA) offers academic and industry researchers from Europe and worldwide the opportunity to remotely access the PDX models, services, and expertise of the EurOPDX Research Infrastructure (RI). As part of the EDIReX EU grant, three TA calls were launched between 2018 and 2020.

Please visit https://www.europdx.eu/europdxri-ta to register to be kept informed about future opportunities.

Any question? ...please contact us at ta@europdx.eu


1st call for EurOPDX TA - 31st January 2019 CLOSED - Projects underway

2nd call for EurOPDX TA - 29th November 2019 CLOSED - Projects underway

3rd call for EurOPDX TA - CLOSED 

1st cut-off dates were postponed to 30th April - Projects starting

2nd and last cut-off date postponed to 18th September 2020! - Results expected end of October

 


For further information, including a “guide for applicants” and “application forms” when each call is open: visit: https://www.europdx.eu/europdxri-ta

Applications for Trans-national Access (TA) grants are evaluated by an independent committee of experts, and projects are selected according to scientific excellence and impact through an objective scoring system. Users whose projects are selected for funding will still need to sign a Material Transfer Agreement (MTA) with the owners of the chosen PDX model(s) - this will be facilitated by the EurOPDX RI management team.

Three types of free-of-charge access to PDX resources are available through each of the 6 infrastructure nodes of the EurOPDX RI: 

SAMPLE = shipment of frozen PDX tumour samples to selected users.

No description

DEPOSIT = deposition of PDX models into the repository and infrastructure biobank.

No description

TEST = the performance of in vivo experiments on PDX models with the users’ treatment of choice.

No description

For more information visit: https://www.europdx.eu/europdxri-ta

Any question? ...please contact us at ta@europdx.eu

Go Up

You are running an old browser version. We recommend updating your browser to its latest version.

More info